200 related articles for article (PubMed ID: 30153328)
21. miR-29b promotes skin wound healing and reduces excessive scar formation by inhibition of the TGF-β1/Smad/CTGF signaling pathway.
Guo J; Lin Q; Shao Y; Rong L; Zhang D
Can J Physiol Pharmacol; 2017 Apr; 95(4):437-442. PubMed ID: 28092445
[TBL] [Abstract][Full Text] [Related]
22. Effects of angiotensin converting enzyme inhibitor, angiotensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats.
Zhang RY; Wang LF; Zhang L; Meng XN; Li SJ; Wang WR
Chin Med J (Engl); 2006 Apr; 119(8):649-55. PubMed ID: 16635409
[TBL] [Abstract][Full Text] [Related]
23. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
[TBL] [Abstract][Full Text] [Related]
24. TAK1 is required for dermal wound healing and homeostasis.
Guo F; Hutchenreuther J; Carter DE; Leask A
J Invest Dermatol; 2013 Jun; 133(6):1646-54. PubMed ID: 23340735
[TBL] [Abstract][Full Text] [Related]
25. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
26. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
[TBL] [Abstract][Full Text] [Related]
27. Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.
Gilbert RE; Cox A; Wu LL; Allen TJ; Hulthen UL; Jerums G; Cooper ME
Diabetes; 1998 Mar; 47(3):414-22. PubMed ID: 9519748
[TBL] [Abstract][Full Text] [Related]
28. Angiotensin II and the fibroproliferative response to acute lung injury.
Marshall RP; Gohlke P; Chambers RC; Howell DC; Bottoms SE; Unger T; McAnulty RJ; Laurent GJ
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L156-64. PubMed ID: 12754187
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin suppresses epithelial to mesenchymal transition and intercepts Smad signal transduction through a MEK-dependent mechanism in pig kidney (LLC-PK1) cell lines.
Chen CL; Chou KJ; Lee PT; Chen YS; Chang TY; Hsu CY; Huang WC; Chung HM; Fang HC
Exp Cell Res; 2010 Apr; 316(7):1109-18. PubMed ID: 20202468
[TBL] [Abstract][Full Text] [Related]
30. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
31. Endogenous CCN5 Participates in Angiotensin II/TGF-β
Huang A; Li H; Zeng C; Chen W; Wei L; Liu Y; Qi X
Front Pharmacol; 2020; 11():1235. PubMed ID: 33013358
[TBL] [Abstract][Full Text] [Related]
32. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
[TBL] [Abstract][Full Text] [Related]
33. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
[TBL] [Abstract][Full Text] [Related]
34. The compound losartan cream inhibits scar formation via TGF-β/Smad pathway.
Zhao WY; Zhang LY; Wang ZC; Fang QQ; Wang XF; Du YZ; Shi BH; Lou D; Xuan GD; Tan WQ
Sci Rep; 2022 Aug; 12(1):14327. PubMed ID: 35995975
[TBL] [Abstract][Full Text] [Related]
35. An ACE inhibitor reduces bactericidal activity of human neutrophils in vitro and impairs mouse neutrophil activity in vivo.
Cao DY; Giani JF; Veiras LC; Bernstein EA; Okwan-Duodu D; Ahmed F; Bresee C; Tourtellotte WG; Karumanchi SA; Bernstein KE; Khan Z
Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321319
[TBL] [Abstract][Full Text] [Related]
36. Dual inhibition of ACE and NEP provides greater cardioprotection in mice with heart failure.
Xu J; Carretero OA; Liu YH; Yang F; Shesely EG; Oja-Tebbe N; Yang XP
J Card Fail; 2004 Feb; 10(1):83-9. PubMed ID: 14966779
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.
Painemal P; Acuña MJ; Riquelme C; Brandan E; Cabello-Verrugio C
Biofactors; 2013; 39(4):467-75. PubMed ID: 23460581
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts.
Gao X; He X; Luo B; Peng L; Lin J; Zuo Z
Eur J Pharmacol; 2009 Mar; 606(1-3):115-20. PubMed ID: 19374881
[TBL] [Abstract][Full Text] [Related]
39. Multiwall carbon nanotubes mediate macrophage activation and promote pulmonary fibrosis through TGF-β/Smad signaling pathway.
Wang P; Nie X; Wang Y; Li Y; Ge C; Zhang L; Wang L; Bai R; Chen Z; Zhao Y; Chen C
Small; 2013 Nov; 9(22):3799-811. PubMed ID: 23650105
[TBL] [Abstract][Full Text] [Related]
40. Smad6 inhibits non-canonical TGF-β1 signalling by recruiting the deubiquitinase A20 to TRAF6.
Jung SM; Lee JH; Park J; Oh YS; Lee SK; Park JS; Lee YS; Kim JH; Lee JY; Bae YS; Koo SH; Kim SJ; Park SH
Nat Commun; 2013; 4():2562. PubMed ID: 24096742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]